However, after a series of thorough investigations and an inspection by a US health agency, it was found that the practices in the Theranos laboratory were deficient and still put the health and safety of patients at risk, which ended up leading to the company's CEO being convicted of fraud.
Initially, after the creation of Anvisa, many companies had difficulty keeping up with the market changes imposed by the new regulatory control model. To meet the requirements, the sector needed to invest in more research and innovative solutions.
All this transformation, after a certain amount of time, resulted oman mobile database in a positive balance. The level of excellence required by regulatory bodies highlighted the importance and need to have highly qualified and trained professionals, opening up more and more space for new opportunities.
And while the opportunities are numerous, regulatory risks also increase proportionally, especially if the company is not prepared to deal with an extremely regulated environment. In the pharmaceutical industry, a wrong decision or failure to follow current legislation can lead to serious problems and significant loss of value.
To face the obstacles of this environment, it is essential to have intelligence that provides relevant information for your business in a fast and organized manner, so that you can make safe and timely decisions. Inteligov understands this need in the sector and can help you with your strategy! Click here and contact our experts .